Final Settlement Approved in New England Biolabs ESOP Case
On August 7, 2025, a federal district judge in Massachusetts approved a $7,150,000 class settlement for former New England Biolabs, Inc. employees who alleged that the company’s redemption of their ESOP shares was completed at an unfairly low price.
Join or log in to access this content and much more
NCEO membership connects you with the employee ownership community and provides practical resources that empower you to make informed decisions about employee ownership.